Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats-A possible model for schizophrenia

Behavioural Brain Research

Volumn 205, Issue 1, 2009, Pages 96-101

  Baier, Paul Christian ^a   Blume, Annegret ^a   Koch, Jakob ^a   Marx, Aljoscha ^a   Fritzer, Gunther ^a   Aldenhoff, Josef Bernd ^a   Schiffelholz, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Behaviour; CNS; Development; NMDA; Schizophrenia

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DISEASE MODEL; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGING; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; LYMPHOCYTES; MALE; NEUROPSYCHOLOGICAL TESTS; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 70349290568     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.06.018     Document Type: Article

References (41)

1. Tamminga C.A., and Holcomb H.H. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10 (2005) 27-39
2. Grimwood S., Slater P., Deakin J.F., and Hutson P.H. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 10 (1999) 461-465
3. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
4. Humphries C., Mortimer A., Hirsch S., and de Belleroche J. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7 (1996) 2051-2055
5. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
6. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42 (2002) 165-179
7. Coyle J.T., and Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 59 (2004) 491-515
8. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., et al. Diverse psychotomimetics act through a common signaling pathway. Science 302 (2003) 1412-1415
9. Greengard P. The neurobiology of slow synaptic transmission. Science 294 (2001) 1024-1030
10. Blendy J.A. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 59 (2006) 1144-1150
11. Carlezon Jr. W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends Neurosci 28 (2005) 436-445
12. Gorter J.A., Botterblom M.H., Feenstra M.G., and Boer G.J. Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in the adult rat. Neurosci Lett 137 (1992) 97-100
13. Gorter J.A., and Brady R.J. NMDA receptor responses in adult hippocampal CA1 region after neonatal treatment with MK-801: comparison with NMDA receptor responses in the immature rat. Brain Res 665 (1994) 63-68
14. Gorter J.A., Veerman M., and Mirmiran M. Hippocampal neuronal responsiveness to NMDA agonists and antagonists in the adult rat neonatally treated with MK-801. Brain Res 572 (1992) 176-181
15. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J.L., and Johnson K.M. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107 (2001) 535-550
16. Latysheva N.V., and Raevskii K.S. Behavioral analysis of the consequences of chronic blockade of NMDA-type glutamate receptors in the early postnatal period in rats. Neurosci Behav Physiol 33 (2003) 123-131
17. Latysheva N.V., and Rayevsky K.S. Chronic neonatal N-methyl-d-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 787-794
18. Stefani M.R., and Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57 (2005) 433-436
19. Rujescu D., Bender A., Keck M., Hartmann A.M., Ohl F., Raeder H., et al. A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59 (2006) 721-729
20. Schiffelholz T., Hinze-Selch D., and Aldenhoff J.B. Perinatal MK-801 treatment affects age-related changes in locomotor activity from childhood to later adulthood in rats. Neurosci Lett 360 (2004) 157-160
21. Sircar R., and Soliman K.F. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Pharmacol Biochem Behav 74 (2003) 943-952
22. Castner S.A., Goldman-Rakic P.S., and Williams G.V. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl) 174 (2004) 111-125
23. Baker K.B., and Kim J.J. Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn Mem 9 (2002) 58-65
24. Nakazawa K., McHugh T.J., Wilson M.A., and Tonegawa S. NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci 5 (2004) 361-372
25. Kesslak J.P., Chuang K.R., and Berchtold N.C. Spatial learning is delayed and brain-derived neurotrophic factor mRNA expression inhibited by administration of MK-801 in rats. Neurosci Lett 353 (2003) 95-98
26. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor upregulation. Int J Dev Neurosci 21 (2003) 159-167
27. Karasawa J., Hashimoto K., and Chaki S. D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res 186 (2008) 78-83
28. Abe H., Ishida Y., Iwasaki T., and Perirhinal. N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats. Neurosci Lett 356 (2004) 191-194
29. Rampon C., Tang Y.P., Goodhouse J., Shimizu E., Kyin M., and Tsien J.Z. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci 3 (2000) 238-244
30. Farber N.B. The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003 (2003) 119-130
31. Honkonen T., Henriksson M., Koivisto A.M., Stengard E., and Salokangas R.K. Violent victimization in schizophrenia. Soc Psychiatry Psychiatr Epidemiol 39 (2004) 606-612
32. Anastasio N.C., and Johnson K.M. Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat. J Neurochem 104 (2008) 1210-1218
33. Nudmamud-Thanoi S., and Reynolds G.P. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 372 (2004) 173-177
34. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., and Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158 (2001) 1400-1410
35. Boldyrev A.A., Carpenter D.O., and Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J Neurochem 95 (2005) 913-918
36. Miglio G., Varsaldi F., and Lombardi G. Human T lymphocytes express N-methyl-d-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun 338 (2005) 1875-1883
37. Yu C.T., Shih H.M., and Lai M.Z. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation. J Immunol 166 (2001) 284-292
38. Curtis J., and Finkbeiner S. Sending signals from the synapse to the nucleus: possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J Neurosci Res 58 (1999) 88-95
39. Seo M.S., Kim S.H., Ahn Y.M., Kim Y., Jeon W.J., Yoon S.C., et al. The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex. Int J Neuropsychopharmacol 10 (2007) 359-368
40. Lema Tome C.M., Bauer C., Nottingham C., Smith C., Blackstone K., Brown L., et al. MK801-induced caspase-3 in the postnatal brain: inverse relationship with calcium binding proteins. Neuroscience 141 (2006) 1351-1363
41. Eyjolfsson E.M., Brenner E., Kondziella D., and Sonnewald U. Repeated injection of MK801: an animal model of schizophrenia?. Neurochem Int 48 (2006) 541-546